Contact Us: 833-BRA-ND11

Olema

OPERA-01

In the competitive field of oncology, Olema faced the challenge of meeting ambitious enrollment targets for their Phase III clinical trial, OPERA-01.

To drive rapid enrollment, Olema needed to position themselves as a leader in the field, so they enlisted Addison Whitney to craft a clinical trial brand focused on fostering awareness and establishing credibility.

  • Client

    Olema

  • Services

    Research & Insights

    Branding Strategy

    Visual Identity

    Brand Implementation

Building awareness within the competitive oncology space.

To showcase the transformative power of OPERA-01 and inspire hope for those affected by breast cancer, our strategic experts crafted a compelling brand story for Olema. From this story hinges a compassionate and authoritative brand character that defines the presence of the clinical trial in the market.

This brand character was leveraged to create a vibrant visual identity, highlighting Olema’s innovative approach and dedication to revolutionizing breast cancer treatment. The drawn theater curtain symbolizes discovery and exciting possibilities that OPERA-01 research may uncover. The design’s use of white space, seen as a forward-facing arrow, suggests momentum and continuous treatment, while contrasting dark and light shades of magenta reflect the study’s focus on ER-positive, HER2-negative breast cancer; accompanied by a modern sans serif font to add a clean and inviting aesthetic.

 

Establishing credibility around the differentiated asset profile. 

A comprehensive microsite features detailed information about the study, the asset, and an extensive FAQ section. This microsite serves as a central hub for participants and stakeholders, providing them with all the essential details they need to understand the trial’s purpose, benefits, and procedures.​

Facilitating rapid enrollment of patients into the trial.

A patient recruitment tool infused with compelling messaging effectively engages potential participants, highlighting the benefits and importance of the OPERA-01 clinical trial. Both informative and persuasive, the tool leverages the brand’s established credibility to resonate with the target audience and encourage enrollment.

More stories only we can tell

Schedule a demo of Ari™ today.

The first and only proprietary, AI brand design application for pharma naming.

Name(Required)
Last(Required)